Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy for canine lymphosarcoma.

B R Madewell

    American Journal of Veterinary Research
    |October 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Chemotherapy effectively treated canine lymphosarcoma in 17 of 20 dogs, showing significant remission and survival benefits. This combination drug therapy offers a promising approach for canine cancer treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    T-cell-derived malignant lymphoma in the boxer breed.

    Veterinary and comparative oncology·2009
    Same author

    Comparative oncology--new and expanding opportunities for research.

    Veterinary and comparative oncology·2009
    Same author

    A landmark in Veterinary and Comparative Oncology.

    Veterinary and comparative oncology·2009
    Same author

    Cyclin D3 expression in normal fetal, normal adult and neoplastic feline tissue.

    Journal of comparative pathology·2005
    Same author

    Feline vaccine-associated fibrosarcoma: morphologic distinctions.

    Veterinary pathology·2002
    Same author

    "Equine basal cell tumors: 6 cases (1985-1999)".

    Journal of veterinary internal medicine·2001
    Same journal

    Plasma formiminoglutamic acid shows potential as a functional marker of folate deficiency in cats and dogs: development and validation of a liquid chromatography-tandem mass spectrometry method.

    American journal of veterinary research·2026
    Same journal

    Spot urinary electrolytes are associated with decongestion and duration of hospitalization in dogs with acute left-sided congestive heart failure secondary to myxomatous mitral valve disease.

    American journal of veterinary research·2026
    Same journal

    Oral administration of a live-attenuated Bordetella bronchiseptica vaccine (Vanguard B Oral) induces protective immunity against challenge 7 days after vaccination in dogs.

    American journal of veterinary research·2026
    Same journal

    Inertial measurement units are comparable to motion capture for measuring intersegmental spinal angular velocities in horses.

    American journal of veterinary research·2026
    Same journal

    Intra-articular interleukin-1β induces early synovitis in an ex vivo autologously perfused equine forelimb model.

    American journal of veterinary research·2026
    Same journal

    Computed tomographic liver volumetry and hepatic attenuation in dogs with histologically confirmed cirrhosis compared with dogs without liver disease.

    American journal of veterinary research·2026
    See all related articles

    Area of Science:

    • Veterinary Oncology
    • Canine Cancer Research
    • Pharmacological Treatments

    Background:

    • Lymphosarcoma is a common cancer in dogs.
    • Effective treatment strategies for canine lymphosarcoma are crucial for improving outcomes.
    • Combination chemotherapy has shown potential in various cancer types.

    Purpose of the Study:

    • To evaluate the efficacy of combination chemotherapy in dogs with naturally occurring lymphosarcoma.
    • To assess clinical response rates, remission duration, and survival times.

    Main Methods:

    • Histological diagnosis and clinical staging of 20 dogs with lymphosarcoma.
    • Treatment with a combination of corticosteroids, alkylating agents, plant alkaloids, and antimetabolites.
    • Categorization of clinical response as complete, partial, or unsatisfactory.

    Related Experiment Videos

    Main Results:

    • 17 out of 20 dogs (85%) showed a complete or partial response to chemotherapy.
    • The mean objective remission duration was 104.8 days.
    • The mean survival time for all dogs was 211.5 days, and 233.7 days for responders.

    Conclusions:

    • Combination chemotherapy is an effective treatment for canine lymphosarcoma.
    • The studied drug combinations provide significant clinical benefits, including extended remission and survival.
    • Further research into optimized combination protocols is warranted.